Kolexia
Dauba Jerome Oncologie médicale
Dauba Jerome
Oncologie médicale
Centre Hospitalier de Dax
Dax, France
130 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Adénocarcinome Tumeurs colorectales Carcinome pulmonaire non à petites cellules Tumeurs du poumon Tumeurs du côlon Carcinome pulmonaire à petites cellules Tumeurs du sein Métastase tumorale Tumeurs de la prostate

Collaborateurs

Voir plus
Louvet Christophe
Louvet Christophe
Institut Mutualiste Montsouris, Paris, France
Andre Thierry
Andre Thierry
Hôpital Saint-Antoine, Paris, France
Tournigand Christophe
Tournigand Christophe
Hôpital Henri Mondor, Créteil, France
Penager Sarah
Penager Sarah
Centre D'oncologie Et De Radiotherapie, Bayonne, France

Industries

Voir plus
B3TSI
56 collaboration(s)
Dernière en 2023
IQVIA
31 collaboration(s)
Dernière en 2023
A+A
18 collaboration(s)
Dernière en 2023
MSD
9 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
IDEA: A Phase III Randomized Trial Investigating the Duration of Adjuvant Therapy(3 Versus 6 Months) With the Modified FOLFOX 6 or XELOX Regimens for Patients With Stage III Colon Cancer
Essai Clinique (GERCOR (Multidisciplinary Group in Oncology))   27 septembre 2023
1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer: Phase III Randomized Multicenter Trial Comparing Continued Maintenance Therapy With the Bevacizumab + Taxane Versus Bevacizumab + Substituting Exemestane in Patients With Metastatic Breast Cancer or Locally Advanced With Estrogen Receptor Positive and Having at Least a Stable Disease After 16 to 18 Weeks of Treatment With Bevacizumab + Taxane.
Essai Clinique (ARCAGY/ GINECO GROUP)   05 septembre 2023
#construction #constructionlife #activities | Jerome Jane Dauba ...
Facebook   04 septembre 2023
PHRC2003: Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment . Geriatric Oncology Protocol in Aquitaine Country.
Essai Clinique (BMS)   27 janvier 2022
Prognostic Value of Routinely Measured Inflammatory Biomarkers in Older Cancer Patients: Pooled Analysis of Three Cohorts.
Cancers   07 décembre 2021
Tailoring maintenance chemotherapy upon response to induction chemotherapy as compared with pemetrexed continuation maintenance in advanced non-squamous NSCLC patients: Results of the IFCT-GFPC-1101 multicenter randomized phase III trial.
Lung cancer (Amsterdam, Netherlands)   30 novembre 2021
AMA: A Phase II Trial Evaluating the Activity of Abiraterone Acetate Plus Prednisone in Patients With a Molecular Apocrine HER2-negative Locally Advanced or Metastatic Breast Cancer
Essai Clinique (Unicancer)   21 février 2021
Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer: Randomized Phase III Trial Comparing an Association of Hormonal Treatment and Docetaxel Versus the Hormonal Treatment Alone in Metastatic Prostate Cancers
Essai Clinique (Unicancer)   19 février 2021
Switch maintenance chemotherapy versus observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer: IFCT-1201 MODEL trial.
European journal of cancer (Oxford, England : 1990)   06 septembre 2020
Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   13 mars 2020